Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Daily marijuana use increases CAD risk | Ongoing trends in PAD & CLI | Cardiologist honored with her own doll
Monday, February 27, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Daily marijuana use significantly increases risk of coronary artery disease

Monthly marijuana use, meanwhile, was not associated with a greater CAD risk. The full study is scheduled to be presented at ACC.23/WCC in New Orleans.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Daily marijuana use significantly increases risk of coronary artery disease

Share on Twitter Share on Facebook Share on Linkedin
Monthly marijuana use, meanwhile, was not associated with a greater CAD risk. The full study is scheduled to be presented at ACC.23/WCC in New Orleans.
READ MORE >

Hormone therapy for gender dysphoria linked to higher cardiovascular risks

“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."

READ MORE >
Options for choosing transgender gender sex or gender choice are now offered in most PACS and RIS systems.
Share on Twitter Share on Facebook Share on Linkedin

Hormone therapy for gender dysphoria linked to higher cardiovascular risks

Share on Twitter Share on Facebook Share on Linkedin
Options for choosing transgender gender sex or gender choice are now offered in most PACS and RIS systems.
“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."
READ MORE >

What do interventional cardiologists need to treat PAD and CLI?

Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 

READ MORE >
Sahil A. Parikh, MD, Director of Endovascular Services at Columbia University Irving Medical Center and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explained the growing trend or interventional cardiologists treating PAD and CLI. He shares what he thinks is important for cardiology departments to know before expanding expanding their programs in this space.
Share on Twitter Share on Facebook Share on Linkedin

What do interventional cardiologists need to treat PAD and CLI?

Share on Twitter Share on Facebook Share on Linkedin
Sahil A. Parikh, MD, Director of Endovascular Services at Columbia University Irving Medical Center and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explained the growing trend or interventional cardiologists treating PAD and CLI. He shares what he thinks is important for cardiology departments to know before expanding expanding their programs in this space.
Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 
READ MORE >

Canada’s first Black female interventional cardiologist honored with new doll

Alexandra Bastiany, MD, made history when she became Canada’s first Black female interventional cardiologist in 2020. Now, that achievement is being recognized in a surprising way.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Canada’s first Black female interventional cardiologist honored with new doll

Share on Twitter Share on Facebook Share on Linkedin
Alexandra Bastiany, MD, made history when she became Canada’s first Black female interventional cardiologist in 2020. Now, that achievement is being recognized in a surprising way.
READ MORE >

Featured Articles

Confirmed: Long COVID more than doubles a person’s risk of heart issues

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 

READ MORE >
heart_body_blood_bloodvessel.jpg
Share on Twitter Share on Facebook Share on Linkedin

Confirmed: Long COVID more than doubles a person’s risk of heart issues

Share on Twitter Share on Facebook Share on Linkedin
heart_body_blood_bloodvessel.jpg
According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 
READ MORE >

Medtronic relaunches Harmony TPV system after 2022 recall

The device, which gained FDA approval in 2021, was part of a voluntary recall in 2022 due to stability concerns. Medtronic worked with the FDA to address the issue, and the Harmony TPV is once again available throughout the United States. 

READ MORE >
The Medtronic Harmony transcatheter pulmonary valve on display at ACC 2022. The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling the delivery catheter from its Harmony transcatheter pulmonary valve (TPV) system due to a risk of the piece breaking during use.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic relaunches Harmony TPV system after 2022 recall

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Harmony transcatheter pulmonary valve on display at ACC 2022. The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling the delivery catheter from its Harmony transcatheter pulmonary valve (TPV) system due to a risk of the piece breaking during use.
The device, which gained FDA approval in 2021, was part of a voluntary recall in 2022 due to stability concerns. Medtronic worked with the FDA to address the issue, and the Harmony TPV is once again available throughout the United States. 
READ MORE >

New patient-specific heart models could change how cardiologists make treatment decisions

The 3D-printed models are soft, flexible and can mimic the way a patient's heart may respond to different interventions. 

READ MORE >
3D printed heart model soft flexible MIT Cleveland Clinic Harvard Mass General
Share on Twitter Share on Facebook Share on Linkedin

New patient-specific heart models could change how cardiologists make treatment decisions

Share on Twitter Share on Facebook Share on Linkedin
3D printed heart model soft flexible MIT Cleveland Clinic Harvard Mass General
The 3D-printed models are soft, flexible and can mimic the way a patient's heart may respond to different interventions. 
READ MORE >

In Case You Missed It

High-risk patients ineligible for bypass surgery see ‘profound improvements’ after PCI

High-risk patients with complex CAD who are ineligible for CABG can still see substantial benefits from PCI.

READ MORE >
Hackensack Meridian Health, New Jersey’s largest health network, recently announced it has signed a definitive agreement with Complete Care to acquire a majority of its long-term care facilities. 
Share on Twitter Share on Facebook Share on Linkedin

High-risk patients ineligible for bypass surgery see ‘profound improvements’ after PCI

Share on Twitter Share on Facebook Share on Linkedin
Hackensack Meridian Health, New Jersey’s largest health network, recently announced it has signed a definitive agreement with Complete Care to acquire a majority of its long-term care facilities. 
High-risk patients with complex CAD who are ineligible for CABG can still see substantial benefits from PCI.
READ MORE >

In Other News

Low-field MRI systems improve accessibility, but what kind of diagnostic quality do they offer?

Experts recently compared the use of a 0.55T low-field MRI system to a 1.5T system to determine whether the results rendered were within an acceptable diagnostic range.

READ MORE >
0.55T MRI lumbar compared to 1.5T sequence #lumbarMRI #1.5T
Share on Twitter Share on Facebook Share on Linkedin

Low-field MRI systems improve accessibility, but what kind of diagnostic quality do they offer?

Share on Twitter Share on Facebook Share on Linkedin
0.55T MRI lumbar compared to 1.5T sequence #lumbarMRI #1.5T
Experts recently compared the use of a 0.55T low-field MRI system to a 1.5T system to determine whether the results rendered were within an acceptable diagnostic range.
READ MORE >

ACR, other doc groups call for quick end to latest surprise-billing suit in new court filing

Some physicians believe recent guidance from the federal government will make the mechanism for settling payment disputes with insurers “economically infeasible."

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

ACR, other doc groups call for quick end to latest surprise-billing suit in new court filing

Share on Twitter Share on Facebook Share on Linkedin
Some physicians believe recent guidance from the federal government will make the mechanism for settling payment disputes with insurers “economically infeasible."
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide
Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme